Sylvain Salignac
About
In The Last Decade
Sylvain Salignac
22 papers receiving 258 citations
Peers
Comparison fields: 5 of 54
- Hematology 118
- Immunology 72
- Oncology 51
- Pulmonary and Respiratory Medicine 50
- Cardiology and Cardiovascular Medicine 45
Countries citing papers authored by Sylvain Salignac
This map shows the geographic impact of Sylvain Salignac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvain Salignac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvain Salignac more than expected).
Fields of papers citing papers by Sylvain Salignac
This network shows the impact of papers produced by Sylvain Salignac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvain Salignac. The network helps show where Sylvain Salignac may publish in the future.
Co-authorship network of co-authors of Sylvain Salignac
This figure shows the co-authorship network connecting the top 25 collaborators of Sylvain Salignac. A scholar is included among the top collaborators of Sylvain Salignac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvain Salignac. Sylvain Salignac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 31 | |
| 5 | 10 | |
| 6 | 4 | |
| 7 | 11 | |
| 8 | 14 | |
| 9 | 69 | |
| 10 | 1 | |
| 11 | 10 | |
| 12 | 2 | |
| 13 | 1 | |
| 14 | 3 | |
| 15 | 17 | |
| 16 | 34 | |
| 17 | 31 | |
| 18 | [Solid tumor in terminal phase: interpretation of biologic anomalies (hematologic tests)]. | 1 |
| 19 | [Schistocytes: which definition should be taken and which method should be used to identify and count them?]. | 3 |
| 20 | [Is detection of schizocytes by computerised image analysis accurate?]. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.